Biosyent Balance Sheet
Biosyent's total assets for Q4 2025 were C$49.44M, an increase of 3.46% from the previous quarter. TSE:RX total liabilities were C$7.97M for the fiscal quarter, a 1.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.